|
1) Gatter K, Warnke R. Intravascular large B-cell lymphoma. In: Jaffe E, Harris N, Stein H, et al, editors. In: Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press; 2001. p. 177-8
|
|
|
|
|
2) Pfleger V, Tappeiner J. Zur Kenntnis der systemisierten Endotheliomatose der cutanen Blutgef(ass)e (Reticuloendotheliose？). Der Hautarzt. 1959; 10: 363-9
|
|
|
|
|
3) Mori S, Itoyama S, Mohri N, et al. Cellular characteristics of neoplastic angioendotheliosis. An immunohistological marker study of 6 cases. Virchows Arch A Pathol Anat Histopathol. 1985; 407: 167-75
|
|
|
|
|
|
4) Ponzoni M, Ferreri AJ, Campo E, et al. Definition, diagnosis, and management of intravascular large B-cell lymphoma: proposals and perspectives from an international consensus meeting. J Clin Oncol. 2007; 25: 3168-73
|
|
|
|
|
5) Shimazaki C, Inaba T, Shimura K, et al. B-cell lymphoma associated with haemophagocytic syndrome: a clinical, immunological and cytogenetic study. Br J Haematol. 1999; 104: 672-9
|
|
|
|
|
|
6) Murase T, Nakamura S, Tashiro K, et al. Malignant histiocytosis-like B-cell lymphoma, a distinct pathologic variant of intravascular lymphomatosis: a report of five cases and review of the literature. Br J Haematol. 1997; 99: 656-64
|
|
|
|
|
|
7) Murase T, Nakamura S, Kawauchi K, et al. An Asian variant of intravascular large B-cell lymphoma: clinical, pathological and cytogenetic approaches to diffuse large B-cell lymphoma associated with haemophagocytic syndrome. Br J Haematol. 2000; 111: 826-34
|
|
|
|
|
|
8) Murase T, Yamaguchi M, Suzuki R, et al. Intravascular large B-cell lymphoma (IVLBCL): a clinicopathologic study of 96 cases with special reference to the immunophenotypic heterogeneity of CD5. Blood. 2007; 109: 478-85
|
|
|
|
|
|
9) Ferreri AJ, Campo E, Seymour JF, et al. Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the ‘cutaneous variant'. Br J Haematol. 2004; 127: 173-83
|
|
|
|
|
|
10) Yamaguchi M, Seto M, Okamoto M, et al. De novo CD5＋ diffuse large B-cell lymphoma: a clinicopathologic study of 109 patients. Blood. 2002; 99: 815-21
|
|
|
|
|
|
11) Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 2000; 403: 503-11
|
|
|
|
|
|
12) Hans CP, Weisenburger DD, Greiner TC, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood. 2004; 103: 275-82
|
|
|
|
|
|
13) Ferreri AJ, Campo E, Ambrosetti A, et al. Anthracycline-based chemotherapy as primary treatment for intravascular lymphoma. Ann Oncol. 2004; 15: 1215-21
|
|
|
|
|
|
14) Reff ME, Carner K, Chambers KS, et al. Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20. Blood. 1994; 83: 435-45
|
|
|
|
|
|
15) Coiffier B, Lepage E, Briere J, et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med. 2002; 346: 235-42
|
|
|
|
|
|
16) Winter JN, Weller EA, Horning SJ, et al. Prognostic significance of Bcl-6 protein expression in DLBCL treated with CHOP or R-CHOP: a prospective correlative study. Blood. 2006; 107: 4207-13
|
|
|
|
|
|
17) Nyman H, Adde M, Karjalainen-Lindsberg ML, et al. Prognostic impact of immunohistochemically defined germinal center phenotype in diffuse large B-cell lymphoma patients treated with immunochemotherapy. Blood. 2007; 109: 4930-5
|
|
|
|
|
|
18) Bouzani M, Karmiris T, Rontogianni D, et al. Disseminated intravascular B-cell lymphoma: clinicopathological features and outcome of three cases treated with anthracycline-based immunochemotherapy. Oncologist. 2006; 11: 923-8
|
|
|
|
|
|
19) Bazhenova L, Higginbottom P, Mason J. Intravascular lymphoma: a role for single-agent rituximab. Leuk Lymphoma. 2006; 47: 337-41
|
|
|
|
|
|
20) Shimada K, Kosugi H, Narimatsu H, et al. Sustained remission after rituximab-containing chemotherapy for intravascular large B-cell lymphoma. J Clin Exp Hematop. in press
|
|
|
|
|